Literature DB >> 1773331

Failed femorocrural reconstruction does not prejudice amputation level.

G M Tsang1, M C Crowson, N C Hickey, M H Simms.   

Abstract

From January 1985 to December 1989, 500 consecutive patients presented to a single vascular unit with limb-threatening acute or critical ischaemia. Vascular reconstruction was attempted unless the patient had insufficient viable tissue to permit weight bearing or complete absence of run-off vessels in the calf. Fifty patients underwent a primary amputation and 450 patients underwent vascular reconstruction, of whom 265 had a femorocrural bypass. Sixty secondary amputations were performed following femorocrural bypass failure. The below-knee amputation to above-knee amputation ratio (BKA:AKA) was 2.0 in the primary amputation group and 1.1 in the secondary amputation group. Direct comparison between the two groups is not valid as they are clinically different. The combined BKA:AKA ratio was 1.4. This compares favourably with the BKA:AKA ratio of recent published series and figures from the National Amputation and Limb Fitting Services. It suggests that an unselective policy of vascular reconstruction for critical ischaemia does not lead to a higher proportion of above-knee amputations.

Entities:  

Mesh:

Year:  1991        PMID: 1773331     DOI: 10.1002/bjs.1800781223

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  3 in total

1.  Factors influencing the early outcome of major lower limb amputation for vascular disease.

Authors:  W B Campbell; S Marriott; R Eve; E Mapson; S Sexton; J F Thompson
Journal:  Ann R Coll Surg Engl       Date:  2001-09       Impact factor: 1.891

2.  Lower limb amputation: striking the balance.

Authors:  W B Campbell; J A St Johnston; V F Kernick; E A Rutter
Journal:  Ann R Coll Surg Engl       Date:  1994-05       Impact factor: 1.891

3.  Case mix and outcome of patients referred to the vascular service at a district general hospital.

Authors:  J A Michaels; R B Galland
Journal:  Ann R Coll Surg Engl       Date:  1993-09       Impact factor: 1.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.